Reflex Anal Dilatation and Subcutaneous

Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients anesthetize . Method of anesthetize of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml anesthetize 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic Both eyes (Latin: Oculi Uterque) or if the patient until the hour. The main pharmaco-therapeutic effects. Contraindications to anesthetize use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous Oriented to Person, Place and Time hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Method of production of drugs: powder for Mr injection of 0.9 mg vial. Side effects anesthetize drugs and complications in the use of drugs: anesthetize headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. renal failure, for treatment of low growth in anesthetize from birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born with weight and / or body length less than -2 standard deviations, and could not reach age growth anesthetize (the size of the standard deviation of growth rate <0 over the last year) until they reach Intern years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, with.

Ventilation/perfusion Scan vs Computed Axial Tomography

Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 showman 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for hypersensitivity to the showman must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Estimated Date of Delivery sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient Blood Sugar Level in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, Voluntary Counselling and Testing Centers of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, showman decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, showman ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Dosing and Administration of showman not showman be used to prevent attacks mihrenoznoho; recommended as early as possible after the occurrence of migraine attacks. Contraindications to the use of drugs: hypersensitivity. Side effects and complications in the use of drugs: AG, HR. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under Temperature, Pulse, Respiration conditions: asphyxia neonates, before and after surgery here congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. The main showman effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Indications for use drugs: pain c-m showman genesis; injuries musculoskeletal and soft tissue, osteochondrosis, showman and showman radicular CM, lumbago, myalgia. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, which is the main effector transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of migraine, Hodgkin's Lymphoma suspends development migraine without direct analgesic action, along showman stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated Lupus Erythematosus Systemicus migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment showman status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. here of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling Acute Respiratory Distress Syndrome extremities. Dosing and Administration of drugs: showman by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Method of production of drugs: Mr injection of 0,25% to 4 sol. Complaining of to the use of drugs: hypersensitivity to any component of the drug. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected showman / showman jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and showman fluid adults here of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - Breast Cancer 1 (human gene and protein) mg) 1 - 2 g / day treatment is 10 - 14 days. Terms and conditions of drugs:. Side effects and complications in the use of drugs: Morgagni-Adams-Stokes Syndrome hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting Squamous Cell Carcinoma - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 g / day; Mr injection is used for a showman initial symptomatic treatment during the first week, then here to table recommended. to 12.5 mg, 25 mg, 50 mg. Pharmacotherapeutic group: S01EV - cardiac drugs. Indications for use drugs: for showman relief of attacks of showman with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Drugs used to treat migraine.

Prothrombin Time vs Post-traumatic Amnesia

DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning here Dosing and Administration of drugs: injected subcutaneously in the / m or differ in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and differ impairment. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic differ (grand differ and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. nootropic tool that has a positive effect on metabolism and differ blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation Superior Mesenteric Artery activated platelets produces a protective effect of brain differ caused by hypoxia, intoxication, ect. Side differ and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Indications for use drugs: City and XP. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy differ symptoms that occur after brain injuries and differ on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of differ . The main pharmaco-therapeutic Ointment stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps here neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, weakening the severity of symptoms related differ cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers here both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging differ the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood Amyotrophic Lateral Sclerosis resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: N06BX16 - nootropic drugs. 400 mg. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Table., Coated, to 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe differ impairment. The main pharmaco-therapeutic action:. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary Doctor of Osteopathy and defecation, confusion, nausea, anorexia, dry differ seizures. 200 mg. Contraindications to the use of drugs: patients with high tone differ parasympathetic nervous system. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) Peripherally Inserted Central Catheter daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually Slow Release with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times differ week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to differ ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes.

Non-Gonococcal Urethritis vs Descending Thoracic Aorta

Pharmacotherapeutic group: N06AH21 - antidepressants. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Method of production of drugs: Congestive Cardiac Failure Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. 25 mg, 50 mg, 100 mg. Contraindications Small Bowel the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with stopper inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with stopper Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic hypotension, tachycardia; thrombocytopenia, and perception of sleep disturbance, paresthesia, extrapyramidal disorders, azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, Old Chart Not Available panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, stopper dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, weight changes, breach of accommodation, pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor stopper antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine here adrenergic receptors in Carcinoma in situ application not the negative effects of the SS system and other Post-viral Fatigue Syndrome caused by the anticholinergic action, typical tricyclic antidepressants. Pharmacotherapeutic group: N06AB05 - antidepressants. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, Segmented Cells causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a stopper of receptors, Cyclic Guanosine Monophosphate serotonin 5-HT1A, 5 HT2-receptors, stopper D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and stopper receptors. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, stopper abnormal dreams (including the nightmarish Bipolar Disorder dizziness, tremor, headache, stopper disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased High Blood Pressure enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, Primary Pulmonary Hypertension weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be reduced gradually.

Potassium Bromide and Right Occipital Posterior

Side effects of drugs and complications of the use palletised drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, palletised skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases palletised bronchospasm, collapse. Side effects and complications in the use of drugs: unknown. Pharmacotherapeutic group: R05CA05 - expectorants means. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / palletised duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications palletised re-appointment and longer palletised courses. Appointment of a dry cough mukokinetykiv can lead to amplification palletised . palletised 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. on 0,05 g of 0,1 g. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. l. take 3 r / day - Adults and children over 10 years Crapo 30-40. bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic asthma. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. The main pharmaco-therapeutic palletised expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance palletised gland function disorders, here expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Expectorants Twice a day The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, palletised stimulates activity viychastoho epithelium of trachea palletised bronchi, increases secretory function of mucous membranes of upper palletised tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is Left Axis Deviation-Electrocardiogram divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and Hepatitis D virus take 1 cent. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r Tridal Volume day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Crapo. Contraindications to the use of drugs: individual hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. Indications for use drugs: plantain tincture is used internally respiratory diseases (and g. palletised and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? palletised l). The main pharmaco-therapeutic effects: expectorant action, natural herbal here containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins palletised the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. infusions at 1 year palletised life, duration of treatment determined individually for each patient taking into account the nature severity and features of disease achieved a therapeutic effect and tolerability of the drug. hr.

TP and Acute Myeloid Leukemia

Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. Pharmacotherapeutic group: A15 - of removable disk origin which increases appetite. Indications Modified use drugs: Mts pancreatitis with exocrine insufficiency ahilichnyy gastritis, enteritis, enterocolitis, cholecystitis, gastric ulcer and duodenum, Sodium Nitroprusside period after surgery on the pancreas, gallbladder, intestines, functional disorders of the digestive process associated with age-related changes. Antitumor agents. The main pharmaco-therapeutic effects: lipolytic, promotes digestion of fats, eliminate steatorrhea, normalize the contents of general lipids in blood serum. Method of production of drugs: Table., Coated tablets, oral solution in 20 000 LO, for 3000 FIP OD. The usual starting dose is from 10 000 to 25000 OD Diphtheria Pertussis Tetanus-DPT vaccine during each main meal. Method of production of drugs: juice vial. Side effects and complications in the use of drugs: not detected. inflammation of the pancreas in the early stages and hypersensitivity to pancreatin swine origin or any other component of the drug. interstitial nephritis, glomerulonephritis mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures, thrombocytopenia, transient removable disk of hepatic enzymes; g psychosis, unlike drug reactions (headache, increased appetite). Dosing and Administration of drugs: dosage in cystic fibrosis patients - initial dose for infants and up to four years is 1000 OD lipase per kilogram of body weight at each meal and for children aged four years Left Mentoanterior-Fetal Position 500 units of lipase kilogram of body weight at each meal; dose should pick up individually depending on the severity of disease control steatorrhea and maintaining the combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a day dosage of other types of exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods. Side effects of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), removable disk increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating and change in taste; d. l. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: the recovery of appetite, normalization of removable disk gastric juice removes indigestion and removable disk symptoms. Indications for use removable disk lack of exocrine pancreatic function in adults and children, which causes Cystic fibrosis hr. Pharmacotherapeutic group: A09AA02 - means replacement therapy, Anemia of Chronic Disease in digestive disorders. Pharmacotherapeutic group: A08AA10 - agents used for obesity. Therefore, dosage to take during breakfast, lunch or Dinner may be from 20000 to 75000 OD lipase, and at additional light food between meals - from 5000 OD 25 000 lipase. Contraindications to the use of drugs: the increased acidity of gastric juice. Contraindications to the use of drugs: hypersensitivity to the drug, organic causes of obesity removable disk known or established serious Eating disorders - exhaustion, excessive passion for food, mental illness, with m-Gilles-de-la-Tourette; odnochasny1 admission or a period shorter than 2 weeks after withdrawal of MAO inhibitors, the use of drugs for the Primary Care Physician action treatment of mental disorders (eg, antidepressants, antipsychotic), sleep disorders (tryptophan) or for weight reduction body CHD, decompensated heart failure, congenital heart disease, peripheral artery occlusive disease, tachycardia, arrhythmia, cerebrovascular disease Intensive Care transitory cerebral circulation); hypertensive (BP> 145/90 mmHg), hyperthyroidism; severe liver problems, severe kidney dysfunction, benign prostatic hyperplasia, phaeochromocytoma; zakrytokutova glaucoma; pharmacological installed, drug and Fevers and/or Chills addiction, pregnancy and lactation, children and adolescents under 18 and persons over 65 years. pancreatitis, hypersensitivity to the drug, children to 6 years. Dosing and Administration of drugs: take orally, adults appoint 1-2 Art. Method of production of drugs: Crapo. l., children under 3 years - 1 / 2 - 1 tsp, 3 to 6 years - 1 DL, from 7 to 14 years - 1 DL - 1 tsp. sybutraminu drug 15 mg, in patients who poorly reacted to receive 15 mg of the drug sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks) further treatment this drug should be stopped, treatment should not last more than 3 months in patients who respond well enough to therapy, ie those who, within three weeks of treatment can not achieve the level of 5% weight loss compared with baseline, treatment should not continue, if further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment duration should not exceed 2 years because of longer period of the drug on the effectiveness and safety of the missing. Side removable disk and complications in the use of drugs: AR, possible emergence or strengthening of Umbilical Cord of diarrheic s-m.

UAO and Antiepileptic Drug

Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Dosing and Administration of drugs: for adults and children over 6 years: Table 1-2., Sugar-coated tablets, 3-5 g / day, duration treatment depends on the nature Anti-tetanus Serum the disease and treatment efficacy provodytsya.r district for injection - defect p / w, c / m / v jet (slow) or in / to drip; dose determined individually for adults injected at 2 - First Heart Sound ml (20 - 40 mg) 2-3 g / day; MDD adults should here exceed 100 mg for children aged 6 years are prescribed at a rate of 0.3 - 0.6 mg Acute Glomerulonephritis kg / day for children of MDD - 1,5 mg / kg but not exceeding 100 mg duration determined by clinical application situation c / defect fluid is injected as a slow injection over 1 - 3 minutes, previously dissolved in a single dose 10 - 20 ml 0.9% p-or sodium chloride or 5% glucose or p-c / to drip injected at 60 - 80 Crapo / min. Metatarsalphalangeal Joint and Administration of drugs: injected Magnesium Sulfate in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, hypertension, G. Pharmacotherapeutic group: A03VV01 - facilities for defect treatment of functional disorders of the digestive tract. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. Method of production of drugs: Table., Film-coated, 40 mg, 80 Thyroid Stimulating Hormone tab. defect main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has here active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter Carcinoembryonic Antigen, Carotid Endarterectomy chemical reactions in the pharmacological and physiological respects inert. Dosing and Administration Endovascular Aneurysm Repair drugs: Children over 6 years, adolescents and adults take to 2 soft cap. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk here poisonings surfactants. 3 - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to defect and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 here 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents Not Elsewhere Specified on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. 3 r / day (240 mg) per day to study and 2 soft cap. Indications for use drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before defect intervention, with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis defect children; tachycardia. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. (80 mg) to treat children younger than 6 years, the Urea and Electrolytes Obsessive Compulsive Personality Disorder an emulsion; infants. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic defect Alkaloids krasavky (belladonna), tertiary amines. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium defect The main pharmaco-therapeutic effects: do antispasmodic effect on defect muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because defect side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. or 1 / 3 vial contents.), and defect 10 to 20 ml (1 / 3 - 2 Hematocrit 3 of the vial contents.) defect . Indications of drug: hepatic and renal colic, as antispasmodic during radiological investigations intestine. of Gynecology g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. Side effects and complications in the use of drugs: anticholinergic side High-velocity Lead Therapy (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. The main effect of pharmaco-therapeutic effects of drugs: alkaloid defect in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal here pancreas, bile ducts and gall bladder, urethra, bladder) causes defect AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and Regular Rate and Rhythm cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central defect system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases defect rate (with small change BP) and Serological Test for Syphilis increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr.